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Abstract
Backround: The aim of the present study was to assess the effects of zinc or copper and polyphenolic
compounds on the 8-isoprostaglandin F2a concentration in the serum and urine of rats with mammary cancer
(adenocarcinoma) induced with 7,12-dimethylbenz[a]antracene. The research focused on the kinetics of alterations
in urinary 8-isoPGF2a at the early stage of carcinogenesis as well as the influence of dietary factors on the process.
The impact of selected compounds on the intensity of DMBA - induced carcinogenesis was also assessed.
Result and conclusions: Administration of DMBA, a compound that inducers mammary tumors in experimental
animals, increased the serum and urinary 8-isoPGF2a levels in study rats. In the rat model, diet supplementation
with zinc, combined with selected polyphenolic compounds (resveratrol or genistein) yielded a statistically
significant decrease in the rat serum and urinary biomarker concentration with a simultaneously significant
stimulation of carcinogenesis.
The results indicate that there is an inverse correlation between the intensity of DMBA-induced carcinogenicity and
the level of 8-isoPGF2a in urine and serum of rats.
Introduction
Breast cancer represents the most common neoplastic dis-
ease in females, accounting for up to one third of new
diagnoses of women’s cancer in certain region of the
world. The fundamental issue in breast cancer control is
prevention, which depends on detection of the determi-
nants of the disease, in terms of initiation and promotion.
It is worth mentioning that despite numerous research
conducted in different areas, currently there is no one
ideal, specific biomarker of the early phase of cancer devel-
opment, including breast cancer. The possibility of using
biomarkers of breast carcinogenesis, such as 8-isoprosta-
glandin F2a, and dietary factors is very promising [1,2].
F2-isoprostanes are the isomers of F-prostaglandin,
produced by cyclooxygenase-independent free radical
peroxidation of arachidonic acid. The formation of 8-
isoPGF2a causes damage to biomembranes and to oxida-
tive modification of plasma lipoproteins. Carcinogenesis
may be initiated by lipid peroxidation, which ultimately
produces damage to proteins and DNA [3].
Another problem is the influence of dietary factor on
biomarkers and the mechanisms of the disease develop-
ment process. It is estimated that approximately
one-third of human cancers are associated with inap-
propriate dietary habits and lifestyle. Therefore, dietary
intake of trace elements and polyphenols becomes an
important factor in controlling oxidative stress and the
pathologies that ensue [4-8].
The aim of the present study was to assess the effect of
zinc or copper and polyphenolic compounds (resveratrol
or genistein) on the concentration of 8-isoprostaglandin
F2a in the serum and urine of rats with mammary cancer
(adenocarcinoma) induced with 7,12-dimethylbenz[a]
antracene. No reports have shown kinetic alterations in
the urinary 8-isoPGF2a quantity excreted at the early
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the process. The impact of selected compounds on the
intensity of DMBA - induced carcinogenesis was also
assessed.
It is still not clear what kind of combinations and
doses of trace elements and polyphenolic compounds
should be given in order to achieve the most beneficial
health effects in human cancer prevention or for
improvement of pharmacological treatment.
Materials and methods
Laboratory animals
Female Sprague-Dawley rats were obtained from the
Animal Laboratory, Department of General and Experi-
mental Pathology, Medical University of Warsaw. The
study was approved by the Ethics Committee, Medical
University of Warsaw. The animals were divided into 12
groups (Table 1). Those in groups 1 to 6 (n = 60) were
treated twice with of 80 mg/kg of body weight DMBA
(Sigma-Aldrich, St. Louis, MO, USA) in rapeseed oil (via
gavage) to induce mammary cancer (adenocarcinoma);
the first treatment was given at 50 days, followed by the
same dose (a repeat dose of 80 mg/kg body weight) at
80 days of rat age. Rats from groups 7 to 12 (control
groups) (n = 40) were accommodated under the same
conditions as those from groups 1 to 6, and received the
same diet, but no DMBA treatment. Tumors were eval-
uated histopathologically to confirm malignancy and to
prove that they were adenocarcinomas (II and III
degree). In DMBA-untreated groups spontaneous can-
cers were not observed.
All animals had a free access to water and food (stan-
dard diet: Labofeed H, Żurawia 19, 89-240 Kcynia,
Poland). Table 1 shows additional different types of
bioelements or polyphenolic compounds also given to
the animals. The rats were fed extra supplements sus-
pended in water, (0.4 ml daily via gavage), from 40 days
until 20 weeks of age (sacrifice time by decapitation).
The animals were fed only the standard diet (without
supplementation) received 0.4 ml of water. The polyphe-
nol dose levels were selected based on human average
daily consumption (extrapolating on the rats’ body
weight) [9,10]. The doses of bioelements were estab-
lished based on the values used in the Labofeed H diet
(standard diet) (77 mg Zn/kg diet; 21.3 mg Cu/kg diet)
[11]. The zinc and copper content in the standard diet
were determined following wet microwave sample
mineralization using atomic absorption spectrophotome-
try (AAS). The dose levels of each agent were selected
for projected drug levels.
In order to obtain rat urine samples, the animals were
placed in individual metabolic cages for 24 hours. Urine
was collected at 10 and 12 weeks of age, at an early,
nonpalpable stage of carcinogenesis. The animals were
sacrificed by decapitation at 20 weeks of age, and serum
were collected. The biomaterial samples were stored at
a temperature of - 70C until the test time.
The concentration of 8-isoPGF2a in serum and urine
was determined by a competitive enzyme-linked immu-
nosorbent assay (ELISA) (8-isoprostane EIA kit, Cayman
Chemical Company (Ann Arbor. MF, USA).
Determination of creatinine level
The 8-isoPGF2a level was standardised by conversion to
the creatinine level. The latter was examined in urine
samples with creatinine test (Hydrex, Warsaw, Poland)
based on Jaffe’s reaction (in an alkaline environment
creatinine forms a colored complex with picric acid).
Superoxide dismutase (SOD) activity
Superoxide dismutase activity in serum was determined
with the Superoxide Dismutase Assay kit, Cayman Che-
mical Company (Ann Arbor, MI). The assay kit utilizes
a tetrazolium salt for detection of superoxide radicals
generated by xanthine oxidase and hypoxanthine. One
unit of SOD is defined as the amount of enzyme needed
to exhibit 50% dismutation of the superoxide radical.
T h eS O Da s s a ym e a s u r e sa l lt h r e et y p e so fS O D( C u /
Zn, Mn and FeSOD).
The animals were examined by palpation during the
study to characterize the time course of tumor develop-
ment. At sacrifice (at 20 weeks of rats’sa g e )t u m o r s
Table 1 Composition of diets administered of different groups
Diets groups/carcinogens
DMBA + DMBA -
1234567891 01 11 2
1. Standard diet ++++++++++ + +
2. Zinc 6.9 mg/mL (231 mg Zn/kg diet) - + - - ---+ -- - -
3. Zinc 6.9 mg/mL (231 mg Zn/kg diet) and resveratrol 0.1 mg/mL (0.2 mg/kg bw) - - + - ----+ - - -
4. Zinc (6.9 mg/mL) (231 mg Zn/kg diet) and genistein 0.1 mg/mL (0.2 mg/kg bw) ---+ -----+- -
5. Copper 1.3 mg/mL (42.6 mg Cu/kg diet) ----+ ----- +-
6. Copper 1.3 mg/mL (42.6 mg Cu/kg diet) and resveratrol 0.1 mg/mL (0.2 mg/kg bw) -----+ ---- - +
Abbreviations: DMBA - 7,12-dimethylbenz[a]anthracene; DMBA (+) corresponds to DMBA-treated groups; DMBA (-) corresponds to DMBA-untreated groups.
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ton was performed.
The results obtained were statistically assessed using
the Kolmogorow-Smirnow test, ANOVA with POST-
HOC NIR tests (SPSS 12 programme).
Results and discussion
Mammary glands of several rat strains, mainly Spraque-
Dawley, are susceptible to transformation induced by
chemical carcinogens. One widely used active chemical
inductors of mammary carcinogenesis is 7,12-dimethyl-
benz[a]anthracene [1]. The results of this study indi-
c a t e dt h a tt h ea m o u n to f8 - i s o P G F 2a in serum and
urines from rats treated with cancerogenic factor and
receiving a standard diet was higher than in the control
group receiving analogous diet but with no DMBA
treatment, however, the differences were not statistically
significant for the reason of high values of standard
deviation (Figures 1, 2 and 3). Similar trend regarding
amount of 8-isoPGF2a in serum of rats treated with car-
bon tetrachloride was acquired by Kadiiska et al. [12].
Administration of DMBA resulted in an increase of
biomarkers indicating damage of DNA (8-hydroxy-2’-
deoxyguanosine), proteins (carbonyl groups of amino
acids) and lipids (8-isoPGF2a) [13]. These findings may
confirm the relationship between DMBA and stimula-
tion of the free radical processes.
It was found that zinc administration combined with
selected polyphenolic compounds (resveratrol or genis-
tein) statistically decreased the biomarker content level in
the rat serum and urine compared with the animals
receiving exclusively a standard diet (p < 0,05) (Figures 1,
2 and 3). It was demonstrated that diet supplementation
with zinc did not decrease the content level of the stu-
died biomarker in serum of DMBA-treated rats. On the
contrary, it stimulated the process (853,576 ± 428,232
versus 897,979 ± 400,809 pg/ml), although, the response
was not statistically significant (p < 0,05). In this case,
synergistic reactions between Zn and polyphenols was
observed. Evidence shows an ability of polyphnols to sca-
vange free radicals, build complexes with metal ions cata-
lysing formation of free radicals, and also inhibiting
certain enzymes participating in oxidation [6-8].
Zn plays an essential role in cell membrane integrity
and is a component of more than 300 different enzymes
that function in many aspects of cellular metabolism. In
numerous systems Zn can antagonize the catalytic prop-
erties of the redox-active transition metals (Fe and Cu)
with respect to their abilities to promote formation of
hydroxyl radical (
.O H )f r o mH 2O2 and superoxide [14].
Surprisingly, the results of our work indicated no con-
nection between superoxide dismutase activity and Zn
or Cu supplemented diets (Table 2). Therefore, the deci-
sion was made to discontinue the search for mutual cor-
relations of 8-isoPGF2a concentration, dependent on the
diet and the enzyme activity, especially, that the rat
group receiving additional zinc exhibited a stimulated
lipid peroxidation (Table 2, Figures 1, 2 and 3). There is
no univocal evidence in the literature to confirm that



























































Figure 1 The content of 8-isoPGF2a (pg/mL) (means ± standard deviation) in serum of DMBA treated and untreated animals in
relation to diet. a - p < 0.05 group treated DMBA, fed standard diet versus groups treated DMBA, fed diet with addition of zinc or copper
separately or in combination with resveratrol and genistein. The date refer to 20 weeks of the animals’ age (decapitation time). Abbreviations:
DMBA - 7,12-dimethylbenz[a]anthracene; DMBA (+) corresponds to DMBA-treated groups; DMBA (-) corresponds to DMBA-untreated groups; 8-
isoPGF2a - 8-isoprostaglandin F2a.
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Page 3 of 6impact on the activity of superoxide dismutase. Reports
seem to indicate that diets supplemented with zinc in
different quantities did not cause significant changes in
SOD activity, what was also confirmed by our study
[15,16].
Many reasearchers have investigated the dietary sup-
plementation effects on the levels of urinary isoprostane
or isoprostane metabolites. Diets rich in fruit and vege-
tables diminish the excretion of urinary 8-isoPGF2a [2].
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Figure 2 Urinary 8-isoPGF2a (ng/mg creatinine) in rats fed different diets in early-onset breast cancer - 10 week of the rodent’s age.a
- p < 0.05 group treated DMBA, fed standard diet versus groups treated DMBA, fed diet with addition of zinc or copper separately or in
combination with resveratrol and genistein. b - p < 0.05 group untreated DMBA, fed standard diet versus groups untreated DMBA, fed diet with
addition of zinc or copper separately or in combination with resveratrol and genistein. Abbreviations: DMBA - 7,12-dimethylbenz[a]anthracene;








































































Figure 3 Urinary 8-isoPGF2a (ng/mg creatinine) in rats fed different diets in early-onset breast cancer - 12 week of the rodent’s age.a
- p < 0.05 group treated DMBA, fed standard diet versus groups treated DMBA, fed diet with addition of zinc or copper separately or in
combination with resveratrol and genistein. b - p < 0.05 group untreated DMBA, fed standard diet versus groups untreated DMBA, fed diet with
addition of zinc or copper separately or in combination with resveratrol and genistein. Abbreviations: DMBA - 7,12-dimethylbenz[a]anthracene;
DMBA (+) corresponds to DMBA-treated groups; DMBA (-) corresponds to DMBA-untreated groups; 8-isoPGF2a - 8-isoprostaglandin F2a.
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plementation with vitamin E [17]. Urinary and plasma
F2-isoprostanes were significantly decreased with
alcohol-free red wine [18].
Cooper is generally considered as a pro-oxidant metal
that participates in Fenon-like reactions. One of the
mechanisms of procancerous Cu activity involves its
ability to produce a strongly reactive hydroxyl radical
responsible for oxidative damage to DNA strands and
also peroxidation of cell membrane lipids [14]. As
shown in our paper, the animals receiving diet supple-
mented with copper or copper and resveratrol had sig-
nificantly higher amount of 8-isoPGF2a in urine
compared with the animals receiving a standard or zinc
supplemented diet (p < 0,05) (Figure 2, 3). This implies
a pro-oxidant effect of cooper.
Another relevant issue in our study was to assess the
severity of carcinogenesis expressed by tumor weight
and number in particular rat groups as well as the onset
of the initial tumors (Table 3). The data refer to tumors
evaluated in 20th week of the animals age (decapitation
time). The largest and most numerous tumors per ani-
mal were found in the group receiving zinc and resvera-
trol supplemented diet, which might have been due to
the fact that in that group the first tumors appeared at
13 weeks of rat age, i.e. two weeks earlier than in the
group fed the standard diet. Zinc compounds are con-
sidered to be chemopreventive agents chiefly due to
their antioxidative properties. However, reports show
that excessive Zn in the animal body may exacerbate
tumorigenesis [14]. The harmful role of Zn in tumori-
genesis could depend on the dose of zinc and synergism
between various antioxidant used in the study. What is
interesting there was an inverse correlation between the
intensity of cancer development process and the level of
8-isoPGF2a in urine and serum of rats. A plausible
explanation of this fact could be that Zn acts to improve
health through a wide variety of biological mechanisms
and not antioxidant activity alone. Thomson et al [19]
reported a moderately significant inverse association of
8-isoPGF2a within plasma carotenoid levels, a protective
association not seen with dietary carotenoid levels.





1. Standard diet DMBA + 19.73 ± 2.82
DMBA - 22.34 ± 1.65
2. Zinc 6.9 mg/mL (231 mg Zn/kg diet) DMBA + 19.52 ± 1.83
DMBA - 19,11 ± 3,77
3. Zinc 6.9 mg/mL (231 mg Zn/kg diet) and resveratrol 0.1 mg/mL (0.2 mg/kg bw) DMBA + 20.81 ± 2.02
DMBA - 21.96 ± 2.31
4. Zinc (6.9 mg/mL) (231 mg Zn/kg diet) and genistein 0.1 mg/mL (0.2 mg/kg bw) DMBA + 19.69 ± 2.67
DMBA - 21.93 ± 2.27
5. Copper 1.3 mg/mL (42.6 mg Cu/kg diet) DMBA + 20.64 ± 2.24
DMBA - 22.29 ± 3.99
6. Copper 1.3 mg/mL (42.6 mg Cu/kg diet) and resveratrol 0.1 mg/mL (0.2 mg/kg bw) DMBA + 19.74 ± 3.20
DMBA - 22.07 ± 4.01
The date refer to serum evaluated at 20 weeks of the animals’ age (decapitation time).
Abbreviations: DMBA - 7,12-dimethylbenz[a]anthracene; DMBA (+) corresponds to DMBA-treated groups; DMBA (-) corresponds to DMBA-untreated groups.







Maximum tumor weight in one
rat in group (g)
First week
at onset
1. Standard diet 9/9 (100) 1-5 12 15
2. Zinc 6.9 mg/mL (231 mg Zn/kg diet) 9/9 (100) 1-5 20 15
3. Zinc 6.9 mg/mL (231 mg Zn/kg diet) and resveratrol 0.1
mg/mL (0.2 mg/kg bw)
10/10 (100) 2-10 30 13
4. Zinc (6.9 mg/mL) (231 mg Zn/kg diet) and genistein 0.1
mg/mL (0.2 mg/kg bw)
10/11 (91) 1-6 15 15
5. Copper 1.3 mg/mL (42.6 mg Cu/kg diet) 9/9 (100) 1-5 7 14
6. Copper 1.3 mg/mL (42.6 mg Cu/kg diet) and resveratrol
0.1 mg/mL (0.2 mg/kg bw)
12/12 (100) 2-6 11 14
The date refer to tumors evaluated at 20 weeks of the animals’ age (decapitation time).
1 Tumor incidence is expressed as the number of tumor-bearing rats over total number of rats in the group.
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Administration of DMBA, a compound that induces
mammary cancer, increased the level of 8-isoPGF2a in
serum and urine of tested rats. In this model, a diet
supplementation with zinc combined with selected
polyphenolic compounds (resveratrol or genistein)
caused statistically significant decrease in concentra-
tion of the studied biomarker (8-isoPGF2a)i nr a t
serum and urine with simultaneous significant stimula-
tion of carcinogenesis. Finally, the level of 8-isoPGF2a
seen in the serum and urine in the rat model did not
indicate a positive correlation with the risk of carcino-
genesis, and this response, to some extent negates the
value of 8-isoPGF2a as a potential determinant of early
pathogenesis of cancer.
List of abbreviations
AAS: atomic absorption spectrophotometry, Cu: copper, DMBA: 7,12-
dimethylbenz[a]anthracene, ELISA: enzyme-linked immunosorbent assay,
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